52020, A NOVEL HUMAN MELANOMA ASSOCIATED ANTIGEN AND USES THEREFOR

Details for Australian Patent Application No. 2002246755 (hide)

Owner MILLENNIUM PHARMACUETICALS, INC.

Inventors MEYERS, Rachel, A.

Pub. Number AU-A-2002246755

PCT Pub. Number WO2002/059314

Priority 60/258,517 28.12.00 US; 10/034,864 27.12.01 US

Filing date 28 December 2001

Wipo publication date 6 August 2002

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C12N 015/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 005/00 Undifferentiated human, animal or plant cells, e.g. cell lines

C07K 014/47 Peptides having more than 20 amino acids

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-A-2002246755

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002246756-USE OF COMBRETASTATIN A4 AND ITS PRODRUGS AS AN IMMUNE ENHANCING THERAPY

2002246754-Pyrazole compounds useful as protein kinase inhibitors